Literature DB >> 23557655

Systemic treatments for severe pediatric psoriasis: a practical approach.

Ann L Marqueling1, Kelly M Cordoro.   

Abstract

Severe psoriasis is uncommon in children, but when it occurs, can be physically, emotionally and socially disabling. Systemic treatments such as phototherapy, acitretin, methotrexate and cyclosporine have been used to manage severe pediatric psoriasis for decades. Newer biologic agents have demonstrated their effectiveness in adult psoriasis and are accumulating promising data in children. This article discusses the use of these treatments including their indications, efficacy, adverse effects, and monitoring requirements. The aim is to provide practical, clinically relevant information regarding the use of these medications alone and in various combinations based on available evidence and cumulative experience.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23557655     DOI: 10.1016/j.det.2012.12.005

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  11 in total

1.  Pediatric Psoriasis Comorbidity Screening Guidelines.

Authors:  Emily Osier; Audrey S Wang; Megha M Tollefson; Kelly M Cordoro; Stephen R Daniels; Andrew Eichenfield; Joel M Gelfand; Alice B Gottlieb; Alexa B Kimball; Mark Lebwohl; Nehal N Mehta; Amy S Paller; Jeffrey B Schwimmer; Dennis M Styne; Abby S Van Voorhees; Wynnis L Tom; Lawrence F Eichenfield
Journal:  JAMA Dermatol       Date:  2017-07-01       Impact factor: 10.282

Review 2.  Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities.

Authors:  I M G J Bronckers; A S Paller; M J van Geel; P C M van de Kerkhof; M M B Seyger
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

Review 3.  Systemic Treatment of Pediatric Psoriasis: A Review.

Authors:  Maddalena Napolitano; Matteo Megna; Anna Balato; Fabio Ayala; Serena Lembo; Alessia Villani; Nicola Balato
Journal:  Dermatol Ther (Heidelb)       Date:  2016-04-16

4.  Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study.

Authors:  D Thaçi; K Papp; D Marcoux; L Weibel; A Pinter; P-D Ghislain; I Landells; P H Hoeger; K Unnebrink; M M B Seyger; D A Williams; S Rubant; S Philipp
Journal:  Br J Dermatol       Date:  2019-07-25       Impact factor: 9.302

5.  Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis.

Authors:  Travis Frantz; Ellen G Wright; Esther A Balogh; Abigail Cline; Adrienne L Adler-Neal; Steven R Feldman
Journal:  Children (Basel)       Date:  2019-11-05

Review 6.  Pros and cons of using systemic acitretin in the paediatric population.

Authors:  Magdalena Sadowska; Joanna Narbutt; Małgorzata Skibińska; Aleksandra Lesiak
Journal:  Postepy Dermatol Alergol       Date:  2020-09-01       Impact factor: 1.837

Review 7.  Management of psoriasis in adolescence.

Authors:  Christina Fotiadou; Elizabeth Lazaridou; Demetrios Ioannides
Journal:  Adolesc Health Med Ther       Date:  2014-03-14

8.  Erythrodermic psoriasis: pathophysiology and current treatment perspectives.

Authors:  Rasnik K Singh; Kristina M Lee; Derya Ucmak; Merrick Brodsky; Zaza Atanelov; Benjamin Farahnik; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Wilson Liao
Journal:  Psoriasis (Auckl)       Date:  2016-07-20

Review 9.  Psoriasis in children.

Authors:  Roxanne Pinson; Bahman Sotoodian; Loretta Fiorillo
Journal:  Psoriasis (Auckl)       Date:  2016-10-20

Review 10.  FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review.

Authors:  Nida Aslam; Hajra Saleem; Salikh Murtazaliev; Sohail J Quazi; Safeera Khan
Journal:  Cureus       Date:  2020-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.